COVID-19 vaccine AZD1222 clinical trials resumed in the UK
Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health ...
Read moreDetails
Tag: COVID-19 Vaccine
Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine
Company working to ensure broad global access to COVID-19 vaccine candidate, following approval from regulators New Brunswick, N.J., August 05, ...
Read moreDetails
Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies
Jul 30, 2020 United States Study published in Nature shows J&J's investigational SARS-CoV-2 vaccine elicits a strong immune response that ...
Read moreDetails
Sanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine
Agreement relates to vaccine candidate using Sanofi’s recombinant protein-based technology combined with GSK’s pandemic adjuvant system Both companies are committed ...
Read moreDetails
Verndari, Inc. Begins Preclinical Testing of COVID-19 Vaccine at University of California, Davis
April 29, 2020 09:00 AM Eastern Daylight Time SACRAMENTO, Calif.--(BUSINESS WIRE)--Verndari, Inc., a biopharmaceutical company in Napa, California, announced today ...
Read moreDetails
Recent News
